Incyte
INCY
#1169
Rank
โ‚ฌ16.57 B
Marketcap
84,42ย โ‚ฌ
Share price
-1.00%
Change (1 day)
16.65%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2025 (TTM): โ‚ฌ1.40 Billion

According to Incyte's latest financial reports the company's current earnings are โ‚ฌ4.81 Billion. In 2024 the company made an earning of โ‚ฌ0.26 Billion a decrease over its 2023 earnings that were of โ‚ฌ0.70 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ1.40 B425%
2024 โ‚ฌ0.26 B-62.04%
2023 โ‚ฌ0.70 B57.66%
2022 โ‚ฌ0.44 B-7.24%
2021 โ‚ฌ0.48 B-345.65%
2020 -โ‚ฌ0.2 Billion-147.7%
2019 โ‚ฌ0.41 B322.02%
2018 โ‚ฌ97.3 M-136.94%
2017 -โ‚ฌ0.27 Billion-390.76%
2016 โ‚ฌ90.6 M1322%
2015 โ‚ฌ6.37 M-115.56%
2014 -โ‚ฌ40.96 Million-41.4%
2013 -โ‚ฌ69.9 Million87.67%
2012 -โ‚ฌ37.25 Million-74.9%
2011 -โ‚ฌ0.15 Billion843.59%
2010 -โ‚ฌ15.73 Million-88.68%
2009 -โ‚ฌ0.14 Billion1.37%
2008 -โ‚ฌ0.14 Billion86.16%
2007 -โ‚ฌ73.61 Million17.64%
2006 -โ‚ฌ62.57 Million-28.62%
2005 -โ‚ฌ87.66 Million-36.1%
2004 -โ‚ฌ0.14 Billion-2.03%
2003 -โ‚ฌ0.15 Billion22.26%
2002 -โ‚ฌ0.12 Billion-27.39%
2001 -โ‚ฌ0.16 Billion198.72%
2000 -โ‚ฌ52.81 Million132.2%
1999 -โ‚ฌ22.74 Million-556.86%
1998 โ‚ฌ4.97 M-37.23%
1997 โ‚ฌ7.92 M-259.32%
1996 -โ‚ฌ4.98 Million-45.87%
1995 -โ‚ฌ9.2 Million-9.17%
1994 -โ‚ฌ10.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ13.85 B 933.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ9.99 B 646.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ18.98 B 1,316.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ6.95 B 419.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ56.34 M-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚ฌ38.75 Million-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚ฌ58.42 Million-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚ฌ24.5 Million-101.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ46.87 Million-103.50%๐Ÿ‡บ๐Ÿ‡ธ USA